Forecasting the burden of type 2 diabetes in Singapore using a demographic epidemiological model of Singapore

Abstract

If the recent rise in obesity prevalence continues, the lifetime risk of type 2 diabetes in Singapore will be one in two by 2050 with concomitant implications for greater healthcare expenditure, productivity losses, and the targeting of health promotion programmes.